EN
HI
Strides Pharma Science share price chart
Strides Pharma Science Share Key Metrics
Volume
89848.00
Market Cap
9208.05 CR
LTQ@LTP
1@1004.30
ATP
996.13
Var Margin
19.6 %
Circuit Range
799.2-1198.8
Delivery %
50.5 %
Value
8.95 CR
ASM/GSM
No
Market Lot
1
Summary
STAR stock price is ₹1004.3 as of 11 Aug, 2026. The stock intraday movement has stayed between ₹986.00 and ₹1012.40, while Strides Pharma Science share price 52 week high low is ₹768.65 & ₹1231.00.
In terms of trading activity, STAR share price has recorded a volume of 89,848 shares. The Strides Pharma Science has a market cap of ₹92172714. The stock’s Average Traded Price (ATP) stands at ₹996.13, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1 @ ₹1004.30.
The Strides Pharma Science upper circuit limit is ₹1198.80 & The Strides Pharma Science lower circuit limit is ₹799.20, with a Value of ₹8.95 CR. The Delivery Percentage for the day is 50.5%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Strides Pharma Science Fundamentals
P/E Ratio
15.04
P/B Ratio
2.82
Div. Yield
0.5
Sector P/E
64.83
Sector P/B
3.28
Sec. Div. Yield
0.51
Strides Pharma Science Resistance and Support
Pivot 1002.33
Resistance
First Resistance
1014.66
Second Resistance
1030.33
Third Resistance
1042.66
Support
First Support
986.66
Second Support
974.33
Third Support
958.66
Strides Pharma Science Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Tue Aug 11 2026 | 1012.4 | 1004.3 | 0.53% | 1012.4 | 986 |
| Mon Aug 10 2026 | 1004.09 | 999 | -0.48% | 1018 | 990 |
| Fri Aug 07 2026 | 998.29 | 1003.79 | 0.66% | 1019.7 | 991 |
Strides Pharma Science Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-31 | Quarterly Results |
| 2026-05-18 | Audited Results & Final Dividend |
| 2026-01-30 | Quarterly Results |
| 2025-10-31 | Quarterly Results |
| 2025-07-29 | Quarterly Results |
| 2025-05-22 | Audited Results & Final Dividend |
| 2025-01-30 | Quarterly Results |
| 2024-10-24 | Quarterly Results |
| 2024-07-29 | Quarterly Results |
Strides Pharma Science News
Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Strides Pharma Science held its Q1 FY27 earnings call, reporting strong performance with a 56.7% YoY increase in reported PAT to Rs.165.5 crore and 17% YoY growth in Ex-US revenue. The company also announced a CARE Ratings upgrade to A+; Stable for Long-Term Bank Facilities.
Aug 03 2026 17:24:32
Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Strides Pharma Science has made the audio recording of its Q1 FY27 earnings call, held on July 31, 2026, available on its website. This recording provides access to the discussion on the company's unaudited financial results for the quarter ended June 30, 2026.
Jul 31 2026 19:32:15
Read More
Strides Pharma Science Management
| Name | Position |
|---|---|
| Arun Kumar | Chairman |
| Kausalya Santhanam | Non Executive Independent Director |
Strides Pharma Science Similar Stocks
Akums Drugs & Pharmaceuticals Ltd.
763.95
33.85 (4.64%)
Sudeep Pharma Ltd.
1108.80
55.50 (5.27%)
Jupiter Life Line Hospitals Ltd.
315.80
-4.20 (1.31%)
Healthcare Global Enterprises Ltd.
716.75
1.10 (0.15%)
Thyrocare Technologies Ltd.
620.15
-1.95 (0.31%)
Suven Life Sciences Ltd.
337.55
4.95 (1.49%)
Procter & Gamble Health Ltd.
5999.50
33.50 (0.56%)
Yatharth Hospital & Trauma Care Services Ltd.
880.20
-18.55 (2.06%)
Sanofi India Ltd.
3312.90
-14.10 (0.42%)
Nephrocare Health Services Ltd.
703.30
5.60 (0.80%)
Strides Pharma Science FAQs
The Buying Price of Strides Pharma Science share is 1004.3 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Strides Pharma Science stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Strides Pharma Science, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Strides Pharma Science shares is 15.04. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Strides Pharma Science shares is 2.82. Useful to assess the stock's value relative to its book value.
To assess Strides Pharma Science’s valuation compare Sector P/E, P/B which are 64.83 & 3.28 with sector averages, along with growth rates and financial metrics.
The Market Cap of Strides Pharma Science is 9208.05 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Strides Pharma Science share price is 1231.00 & 768.65. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Strides Pharma Science belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
